First Header Logo Second Header Logo

Connection

Gopal Badlani to Humans

Back to Details
This is a "connection" page, showing publications Gopal Badlani has written about Humans.
Gopal Badlani
Connection Strength
1.200
Humans
  1. Badlani GH. More Knowledge to Better Predict? Eur Urol. 2020 11; 78(5):711-712.
    View in: PubMed
    Score: 0.039
  2. Badlani G. Re: Is Coexistent Overactive-Underactive Bladder (with or Without Detrusor Overactivity and Underactivity) a Real Clinical Syndrome? Eur Urol. 2020 08; 78(2):287-288.
    View in: PubMed
    Score: 0.039
  3. Zambon JP, Williams KJ, Bennington J, Badlani GH. Applicability of regenerative medicine and tissue engineering for the treatment of stress urinary incontinence in female patients. Neurourol Urodyn. 2019 08; 38 Suppl 4:S76-S83.
    View in: PubMed
    Score: 0.036
  4. Badlani GH. Re: Patient Safety in Vaginal Mesh Surgery. Eur Urol. 2019 03; 75(3):533.
    View in: PubMed
    Score: 0.035
  5. Colaco M, Osman NI, Karakeçi A, Artibani W, Andersson KE, Badlani GH. Current concepts of the acontractile bladder. BJU Int. 2018 08; 122(2):195-202.
    View in: PubMed
    Score: 0.034
  6. Zambon JP, Matthews CA, Badlani GH. Midurethral Slings. J Endourol. 2018 05; 32(S1):S105-S110.
    View in: PubMed
    Score: 0.033
  7. Badlani G. Overactive Bladder: Advancement or More of the Same. Eur Urol. 2018 05; 73(5):791-792.
    View in: PubMed
    Score: 0.033
  8. Zambon JP, Koslov DS, Mihai B, Badlani GH. Bladder and Ureteral Dysfunction Leading to Hydronephrosis and Hydroureteronephrosis in Adults. Urology. 2018 07; 117:1-8.
    View in: PubMed
    Score: 0.033
  9. Hester AG, Kretschmer A, Badlani G. Male Incontinence: The Etiology or Basis of Treatment. Eur Urol Focus. 2017 10; 3(4-5):377-384.
    View in: PubMed
    Score: 0.033
  10. Zambon JP, Badlani GH. Vaginal Mesh Exposure Presentation, Evaluation, and Management. Curr Urol Rep. 2016 Sep; 17(9):65.
    View in: PubMed
    Score: 0.030
  11. Peyton CC, Badlani GH. The management of prostatic obstruction with urethral stents. Can J Urol. 2015 Oct; 22 Suppl 1:75-81.
    View in: PubMed
    Score: 0.028
  12. Badlani GH. Editorial comment. Urology. 2015 Feb; 85(2):331-2.
    View in: PubMed
    Score: 0.027
  13. Colaco M, Mettu J, Badlani G. The scientific basis for the use of biomaterials in stress urinary incontinence (SUI) and pelvic organ prolapse (POP). BJU Int. 2015 Jun; 115(6):859-66.
    View in: PubMed
    Score: 0.026
  14. Badlani GH. Editorial comment. Urology. 2014 Sep; 84(3):581-2.
    View in: PubMed
    Score: 0.026
  15. Mettu JR, Colaco M, Badlani GH. Evidence-based outcomes for mesh-based surgery for pelvic organ prolapse. Curr Opin Urol. 2014 Jul; 24(4):370-4.
    View in: PubMed
    Score: 0.026
  16. Badlani GH. Editorial: advances in female urology. Curr Opin Urol. 2014 Jul; 24(4):329.
    View in: PubMed
    Score: 0.026
  17. Colaco M, Badlani G. Pelvic organ prolapsed in women: Is training beneficial? Natl Med J India. 2014 Mar-Apr; 27(2):86-7.
    View in: PubMed
    Score: 0.025
  18. Peyton CC, Badlani GH. Dedicated research time in urology residency: current status. Urology. 2014 Apr; 83(4):719-24.
    View in: PubMed
    Score: 0.025
  19. Peyton CC, Badlani GH. Reply: To PMID 24508250. Urology. 2014 Apr; 83(4):725.
    View in: PubMed
    Score: 0.025
  20. Colaco M, Sandberg J, Badlani G. Influencing factors leading to malpractice litigation in radical prostatectomy. J Urol. 2014 Jun; 191(6):1770-5.
    View in: PubMed
    Score: 0.025
  21. Badlani G. Editorial comment. Urology. 2013 Jan; 81(1):48-9; author reply 49.
    View in: PubMed
    Score: 0.023
  22. McKenzie P, Badlani GH. The incidence and etiology of overactive bladder in patients after cerebrovascular accident. Curr Urol Rep. 2012 Oct; 13(5):402-6.
    View in: PubMed
    Score: 0.023
  23. Badlani GH. Editorial comment. Urology. 2012 Aug; 80(2):279; author reply 279.
    View in: PubMed
    Score: 0.022
  24. Keys T, Campeau L, Badlani G. Synthetic mesh in the surgical repair of pelvic organ prolapse: current status and future directions. Urology. 2012 Aug; 80(2):237-43.
    View in: PubMed
    Score: 0.022
  25. Badlani GH. Editorial comment. Urology. 2012 Jan; 79(1):14; author reply 15.
    View in: PubMed
    Score: 0.022
  26. Aboushwareb T, McKenzie P, Wezel F, Southgate J, Badlani G. Is tissue engineering and biomaterials the future for lower urinary tract dysfunction (LUTD)/pelvic organ prolapse (POP)? Neurourol Urodyn. 2011 Jun; 30(5):775-82.
    View in: PubMed
    Score: 0.021
  27. Badlani GH, Agarwal M. Editorial comment. Urology. 2010 Dec; 76(6):1362-3; author reply 1363.
    View in: PubMed
    Score: 0.020
  28. McKenzie P, Rohozinski J, Badlani G. Genetic influences on stress urinary incontinence. Curr Opin Urol. 2010 Jul; 20(4):291-5.
    View in: PubMed
    Score: 0.019
  29. Patel BN, Smith JJ, Badlani GH. Minimizing the cost of surgical correction of stress urinary incontinence and prolapse. Urology. 2009 Oct; 74(4):762-4.
    View in: PubMed
    Score: 0.018
  30. Badlani GH. Update on lower urinary tract symptoms. ScientificWorldJournal. 2009 Jun 30; 9:499-500.
    View in: PubMed
    Score: 0.018
  31. Patel B, Bavendam T, Badlani G. Use of antimuscarinics in the elderly. ScientificWorldJournal. 2009 Jun 12; 9:459-65.
    View in: PubMed
    Score: 0.018
  32. Amrute KV, Badlani GH. The science behind biomaterials in female stress urinary incontinence surgery. ScientificWorldJournal. 2009 Jan 18; 9:23-31.
    View in: PubMed
    Score: 0.018
  33. Amrute KV, Eisenberg ER, Rastinehad AR, Kushner L, Badlani GH. Analysis of outcomes of single polypropylene mesh in total pelvic floor reconstruction. Neurourol Urodyn. 2007; 26(1):53-8.
    View in: PubMed
    Score: 0.015
  34. Vanderbrink BA, Rastinehad AR, Badlani GH. Prostatic stents for the treatment of benign prostatic hyperplasia. Curr Opin Urol. 2007 Jan; 17(1):1-6.
    View in: PubMed
    Score: 0.015
  35. Amrute KV, Badlani GH. Female incontinence: a review of biomaterials and minimally invasive techniques. Curr Opin Urol. 2006 Mar; 16(2):54-9.
    View in: PubMed
    Score: 0.014
  36. Karlovsky ME, Kushner L, Badlani GH. Synthetic biomaterials for pelvic floor reconstruction. Curr Urol Rep. 2005 Sep; 6(5):376-84.
    View in: PubMed
    Score: 0.014
  37. Karlovsky ME, Thakre AA, Rastinehad A, Kushner L, Badlani GH. Biomaterials for pelvic floor reconstruction. Urology. 2005 Sep; 66(3):469-75.
    View in: PubMed
    Score: 0.014
  38. Eisenberg ER, Badlani GH. Long-term treatment outcomes of CoreTherm microwave feedback thermotherapy. Curr Urol Rep. 2004 Aug; 5(4):287-94.
    View in: PubMed
    Score: 0.013
  39. Shah DK, Paul EM, Rastinehad AR, Eisenberg ER, Badlani GH. Short-term outcome analysis of total pelvic reconstruction with mesh: the vaginal approach. J Urol. 2004 Jan; 171(1):261-3.
    View in: PubMed
    Score: 0.012
  40. Kushner L, Mathrubutham M, Burney T, Greenwald R, Badlani G. Excretion of collagen derived peptides is increased in women with stress urinary incontinence. Neurourol Urodyn. 2004; 23(3):198-203.
    View in: PubMed
    Score: 0.012
  41. Shah DK, Paul EM, Amukele S, Eisenberg ER, Badlani GH. Broad based tension-free synthetic sling for stress urinary incontinence: 5-year outcome. J Urol. 2003 Sep; 170(3):849-51.
    View in: PubMed
    Score: 0.012
  42. Schachar JS, Ossin D, Plair AR, Hurtado EA, Parker-Autry C, Badlani G, Davila GW, Matthews CA. Optimal timing of a second postoperative voiding trial in women with incomplete bladder emptying after vaginal reconstructive surgery: a randomized trial. Am J Obstet Gynecol. 2020 08; 223(2):260.e1-260.e9.
    View in: PubMed
    Score: 0.010
  43. Overholt TL, Evans RJ, Lessey BA, Matthews CA, Hines KN, Badlani G, Walker SJ. Non-bladder centric interstitial cystitis/bladder pain syndrome phenotype is significantly associated with co-occurring endometriosis. Can J Urol. 2020 06; 27(3):10257-10262.
    View in: PubMed
    Score: 0.010
  44. Desai M, Bidair M, Bhojani N, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys MR, Roehrborn CG, Kaplan S, Motola J, Zorn KC. Aquablation for benign prostatic hyperplasia in large prostates (80-150 cc): 2-year results. Can J Urol. 2020 04; 27(2):10147-10153.
    View in: PubMed
    Score: 0.010
  45. Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP, Trainer A, Arther A, Badlani G, Plante M, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C. Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial. Can J Urol. 2020 02; 27(1):10072-10079.
    View in: PubMed
    Score: 0.009
  46. Nguyen DD, Barber N, Bidair M, Gilling P, Anderson P, Zorn KC, Badlani G, Humphreys M, Kaplan S, Kaufman R, So A, Paterson R, Goldenberg L, Elterman D, Desai M, Lingeman J, Roehrborn C, Bhojani N. Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates. BJU Int. 2020 01; 125(1):112-122.
    View in: PubMed
    Score: 0.009
  47. Walker SJ, Plair A, Hemal K, Langefeld CD, Matthews C, Badlani G, Zambon J, Heath H, Evans RJ. Bladder Hydrodistention Does Not Result in a Significant Change in Bladder Capacity for Interstitial Cystitis/Bladder Pain Syndrome Patients. Urology. 2019 Oct; 132:81-86.
    View in: PubMed
    Score: 0.009
  48. Schachar JS, Evans RJ, Parks GE, Zambon J, Badlani G, Walker SJ. Histological evidence supports low anesthetic bladder capacity as a marker of a bladder-centric disease subtype in interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2019 11; 30(11):1863-1870.
    View in: PubMed
    Score: 0.009
  49. Matthews CA, Deveshwar SP, Evans RJ, Badlani G, Walker SJ. Small fiber polyneuropathy as a potential therapeutic target in interstitial cystitis/bladder pain syndrome. Int Urogynecol J. 2019 11; 30(11):1817-1820.
    View in: PubMed
    Score: 0.009
  50. Bhojani N, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Kaplan S, Motola J, Desai M, Roehrborn C. Aquablation for Benign Prostatic Hyperplasia in Large Prostates (80-150 cc): 1-Year Results. Urology. 2019 Jul; 129:1-7.
    View in: PubMed
    Score: 0.009
  51. Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP, Trainer A, Arther A, Badlani G, Plante M, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C. Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained. Adv Ther. 2019 06; 36(6):1326-1336.
    View in: PubMed
    Score: 0.009
  52. Desai M, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Roehrborn C, Kaplan S, Motola J, Bhojani N. Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trial. BJU Int. 2019 08; 124(2):321-328.
    View in: PubMed
    Score: 0.009
  53. Hines KN, Badlani GH, Matthews CA. Peripartum Perineal Hernia: A Case Report and a Review of the Literature. Female Pelvic Med Reconstr Surg. 2018 Sep/Oct; 24(5):e38-e41.
    View in: PubMed
    Score: 0.009
  54. Plante M, Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP, Trainer A, Arther A, Badlani G, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C. Symptom relief and anejaculation after aquablation or transurethral resection of the prostate: subgroup analysis from a blinded randomized trial. BJU Int. 2019 04; 123(4):651-660.
    View in: PubMed
    Score: 0.009
  55. Desai M, Bidair M, Bhojani N, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Roehrborn C, Kaplan S, Motola J, Zorn KC. WATER II (80-150 mL) procedural outcomes. BJU Int. 2019 01; 123(1):106-112.
    View in: PubMed
    Score: 0.008
  56. Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP, Trainer A, Arther A, Badlani G, Plante M, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol. 2018 05; 199(5):1252-1261.
    View in: PubMed
    Score: 0.008
  57. Caveney M, Haddad D, Matthews C, Badlani G, Mirzazadeh M. Short-term complications associated with the use of transvaginal mesh in pelvic floor reconstructive surgery: Results from a multi-institutional prospectively maintained dataset. Neurourol Urodyn. 2017 Nov; 36(8):2044-2048.
    View in: PubMed
    Score: 0.008
  58. Walker SJ, Zambon J, Andersson KE, Langefeld CD, Matthews CA, Badlani G, Bowman H, Evans RJ. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome. J Urol. 2017 08; 198(2):369-375.
    View in: PubMed
    Score: 0.008
  59. Williams JK, Dean A, Lankford S, Criswell T, Badlani G, Andersson KE. Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiency. Stem Cell Res Ther. 2017 01 06; 8(1):1.
    View in: PubMed
    Score: 0.008
  60. Matthews CA, Eschenroeder A, Badlani G, Evans R, Walker SJ. Evaluation of the efficacy of postmortem human bladder tissue as a normal comparator for case-controlled gene expression studies in urology. Neurourol Urodyn. 2017 04; 36(4):1076-1080.
    View in: PubMed
    Score: 0.007
  61. Williams JK, Dean A, Badlani G, Andersson KE. Regenerative Medicine Therapies for Stress Urinary Incontinence. J Urol. 2016 12; 196(6):1619-1626.
    View in: PubMed
    Score: 0.007
  62. de la Rosette J, Elhilali M, Naito S, Unal D, Razvi H, Liatsikos E, Bachmann A, Tubaro A, Alivizatos G, Mak SK, Badlani G, Eltahawy E, Wong C, Telich Vidal M, Te A, d'Ancona F, Arum CJ, Gutierrez J. Clinical Research Office of the Endourological Society Global GreenLight Laser Study: Outcomes from a contemporary series of 713 patients. Int J Urol. 2015 Dec; 22(12):1124-30.
    View in: PubMed
    Score: 0.007
  63. Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson KE, Walker SJ. Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome. J Urol. 2014 Oct; 192(4):1123-9.
    View in: PubMed
    Score: 0.006
  64. Campeau L, Gorbachinsky I, Badlani GH, Andersson KE. Pelvic floor disorders: linking genetic risk factors to biochemical changes. BJU Int. 2011 Oct; 108(8):1240-7.
    View in: PubMed
    Score: 0.005
  65. Richards KA, Parks GE, Badlani GH, Kader AK, Hemal AK, Pettus JA. Developing selection criteria for prostate-sparing cystectomy: a review of cystoprostatectomy specimens. Urology. 2010 May; 75(5):1116-20.
    View in: PubMed
    Score: 0.005
  66. Zorn KC, Gautam G, Shalhav AL, Clayman RV, Ahlering TE, Albala DM, Lee DI, Sundaram CP, Matin SF, Castle EP, Winfield HN, Gettman MT, Lee BR, Thomas R, Patel VR, Leveillee RJ, Wong C, Badlani GH, Rha KH, Eggener SE, Wiklund P, Mottrie A, Atug F, Kural AR, Joseph JV. Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons. J Urol. 2009 Sep; 182(3):1126-32.
    View in: PubMed
    Score: 0.005
  67. Rastinehad AR, Ost MC, Vanderbrink BA, Greenberg KL, El-Hakim A, Marcovich R, Badlani GH, Smith AD. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy? Urology. 2009 Jan; 73(1):27-31.
    View in: PubMed
    Score: 0.004
  68. Kaye JD, Smith AD, Badlani GH, Lee BR, Ost MC. High-energy transurethral thermotherapy with CoreTherm approaches transurethral prostate resection in outcome efficacy: a meta-analysis. J Endourol. 2008 Apr; 22(4):713-8.
    View in: PubMed
    Score: 0.004
  69. Rastinehad AR, Caplin DM, Ost MC, VanderBrink BA, Lobko I, Badlani GH, Weiss GH, Kavoussi LR, Siegel DN. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology. 2008 Feb; 71(2):181-4.
    View in: PubMed
    Score: 0.004
  70. Lemack GE, Amundsen C, Badlani G, Griebling T, Peters K, Rodriguez L, Singla A, Smith C, Sullivan M, Te A. Highlights from the combined Society of Urodynamics and Female Urology, and International Society of Pelvic Neuromodulation annual meeting. J Urol. 2007 Feb; 177(2):691-5.
    View in: PubMed
    Score: 0.004
  71. Vanderbrink BA, Ost MC, Rastinehad A, Anderson A, Badlani GH, Smith AD, Levine MA, Lee BR. Laparoscopic versus open radical nephrectomy for xanthogranulomatous pyelonephritis: Contemporary outcomes analysis. J Endourol. 2007 Jan; 21(1):65-70.
    View in: PubMed
    Score: 0.004
  72. Chen Y, DeSautel M, Anderson A, Badlani G, Kushner L. Collagen synthesis is not altered in women with stress urinary incontinence. Neurourol Urodyn. 2004; 23(4):367-73.
    View in: PubMed
    Score: 0.003
  73. Shah DK, Paul EM, Badlani GH. 11-year outcome analysis of endourethral prosthesis for the treatment of recurrent bulbar urethral stricture. J Urol. 2003 Oct; 170(4 Pt 1):1255-8.
    View in: PubMed
    Score: 0.003
  74. Shah DK, Kapoor R, Badlani GH. Experience with urethral stent explantation. J Urol. 2003 Apr; 169(4):1398-400.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.